Slingshot Insights | Ibrx Overview

IBRX Overview

Upcoming Projects (IBRX)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (IBRX)

Discussing new data on AstraZeneca’s Imfinzi (durvalumab) in NMIBC and Roche’s Tecentriq (atezolizumab) in MIBC Presented at ESMO 2025
Tickers: AZN, RHHBY, NTRA, PFE, IBRX, CGON, MRK, JNJ, URGN, AURA, TARA, BMY
Executed On: Dec 08, 2025 at 06:00 PM EST
A Second View: Examining ImmuityBio's novel therapeutic approach to BCG-unresponsive high grade NMIBC combining Anktiva (N-803) with intravesical BCG and its recent Phase 2/3 QUILT3.032 Trial results presented at ASCO-GU
Ticker: IBRX
Executed On: Mar 22, 2022 at 01:30 PM EDT
Examining ImmuityBio's novel therapeutic approach to BCG-unresponsive high grade NMIBC combining Anktiva (N-803) with intravesical BCG and its recent Phase 2/3 QUILT3.032 Trial results presented at ASCO-GU
Ticker: IBRX
Executed On: Mar 02, 2022 at 09:30 AM EST
Examining the potential of ImmunityBio’s combination immunotherapy, Nant Cancer Vaccine in pancreatic cancer
Ticker: IBRX
Executed On: Feb 01, 2022 at 03:00 PM EST

Upcoming & Overdue Catalysts (IBRX)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (IBRX)

Don’t see a strategic initiative related to the company you care about? Create your own!